Curis Inc. (CRIS) intrinsic value & 10-year financials

Curis Inc. (CRIS) has a Graham intrinsic value of $3.58 per share. At $0.41 on Oct 17, 2026, the stock trades 89% below that value. Over the last 10 fiscal years revenue grew 2.5% a year to $9.4M, with an average return on invested capital of -22.4%.

Graham intrinsic value
$3.58
Share price (Oct 17, 2026)
$0.41
Price vs Graham value
89% below
Market cap
$5.4M
Revenue (FY2025)
$9.4M
Revenue growth (10-yr CAGR)
2.5%
ROIC (10-yr avg)
-22.4%
Free cash flow (FY2025)
—

CRIS 10-year financial history

Fiscal year Revenue Net income EPS (diluted) Free cash flow Operating margin ROIC
FY2025 $9.4M -$7.6M -$0.58 — -60.5% 71.4%
FY2024 $10.9M -$43.4M -$3.44 — -408.3% 643.7%
FY2023 $10.0M -$47.4M -$4.48 -$38.4M -482.2% -290.2%
FY2022 $10.2M -$56.7M $0.30 -$54.8M -521.7% -133.7%
FY2021 $10.6M -$45.4M -$0.25 -$37.6M -395.0% -147.3%
FY2020 $10.8M -$29.9M -$0.30 -$26.4M -229.8% 140.1%
FY2019 $10.0M -$32.1M -$0.48 -$26.2M -243.5% 153.1%
FY2018 $10.4M -$32.6M — -$30.1M -281.3% -188.2%
FY2017 $9.9M -$53.3M — -$48.5M -502.7% -211.8%
FY2016 $7.5M -$60.4M — -$36.1M -771.1% -261.7%

Source: annual 10-K filings on SEC EDGAR. Figures in USD.

Executive summary

CURIS INC has demonstrated mature, steady growth, with revenue compounding at 2.6% annually over the past decade.

CURIS INC has historically struggled to out-earn its cost of capital, averaging just -7.1% ROIC.

CURIS INC has not shown aggressive share repurchases (>10% retirement) or a major balance-sheet leverage increase (>50% net debt growth) over the 10-year window.

Benjamin Graham lens

Under Benjamin Graham's formula using SEC EDGAR fundamentals, CURIS INC is modeled at 2.5% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $3.58 per share.

CRIS stock: frequently asked questions

What is the intrinsic value of Curis Inc. (CRIS) stock?

Using Benjamin Graham's revised formula, V = EPS × (8.5 + 2g) × 4.4 / Y, with reported diluted earnings per share, a 2.5% normalized growth rate (capped at 15%) and a 5.1% AAA corporate bond yield, CRIS's intrinsic value is about $3.58 per share.

Is CRIS stock undervalued?

At $0.41 (close on Oct 17, 2026), CRIS trades 89% below its Graham value of $3.58. On Graham's terms that leaves a margin of safety. A formula is a starting point for research, not a recommendation.

How fast has Curis Inc. grown?

Revenue went from $7.5M in fiscal 2016 to $9.4M in fiscal 2025, a compound annual growth rate of 2.5%. Net income was -$7.6M in fiscal 2025.

What is CRIS's return on invested capital?

Average ROIC over the last 10 fiscal years was -22.4%, and average return on equity was 129.2%. Sustained ROIC above about 15% usually points to a durable competitive advantage.

Where does this CRIS data come from?

From Curis Inc.'s annual 10-K filings on SEC EDGAR, most recently filed May 13, 2026. Prices are end-of-day snapshots; valuations are formula outputs, not investment advice.

Similar biological products stocks